Fig. 2From: Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with localized primary gastrointestinal stromal tumorsTime-dependent ROC curve analysis for predicting recurrence-free survival in patients with localized primary GIST. According to the modified NIH criteria, SUVmax, MTV, and TLG. All variables are adjusted with regard to adjuvant imatinib treatment. SUV, standard uptake value; MTV, metabolic tumor volume; TLG, total lesion glycolysis; ROC, receiver operating characteristicsBack to article page